IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven...

MILESEEY Tools und magicplan geben strategische Partnerschaft bekannt und stellen gemeinsames Co-Branding S50R-Lasermessset vor

Finance firms face surging AI risks as conduct incidents average USD 14 million